Lihat Juga

• Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
  oleh: Wang, Huijuan
  Terbitan: (2019)
• Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
  oleh: Wang, Huijuan
  Terbitan: (2019)
• Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
  oleh: Wang, Huijuan
  Terbitan: (2019)
• Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
  oleh: Wang, Huijuan
  Terbitan: (2019)
• Perbandingan Efikasi Dan Toksisitas Hematologi Kemoterapi Lini I Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Jenis Karsinoma Sel Skuamosa (KSS) Dengan Adenokarsinoma EGFR wild typeDi RSUP Persahabatan = The Efficacy and Hematological Toxicity of First-line Chemotherapy of Non-small Cell Lung Cancer (NSCLC) Patients Treated at Persahabatan Hospital Jakarta, Indonesia
  oleh: Enita Mayasari
  Terbitan: (2018)